Allspring Global Investments’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.64M | Sell |
76,045
-20,374
| -21% | -$2.32M | 0.01% | 766 |
|
|
2025
Q1 | $10.1M | Sell |
96,419
-3,643
| -4% | -$383K | 0.02% | 712 |
|
|
2024
Q4 | $10.7M | Sell |
100,062
-15,418
| -13% | -$1.65M | 0.02% | 735 |
|
|
2024
Q3 | $11.6M | Buy |
115,480
+16,446
| +17% | +$1.65M | 0.02% | 720 |
|
|
2024
Q2 | $8.34M | Buy |
99,034
+13,839
| +16% | +$1.17M | 0.01% | 813 |
|
|
2024
Q1 | $6.23M | Buy |
85,195
+48,022
| +129% | +$3.51M | 0.01% | 900 |
|
|
2023
Q4 | $2.65M | Buy |
37,173
+18,472
| +99% | +$1.32M | ﹤0.01% | 1103 |
|
|
2023
Q3 | $1.12M | Sell |
18,701
-40,726
| -69% | -$2.44M | ﹤0.01% | 1332 |
|
|
2023
Q2 | $4.28M | Buy |
59,427
+51,639
| +663% | +$3.72M | 0.01% | 1038 |
|
|
2023
Q1 | $573K | Sell |
7,788
-21,194
| -73% | -$1.56M | ﹤0.01% | 1557 |
|
|
2022
Q4 | $1.94M | Buy |
28,982
+24,708
| +578% | +$1.65M | ﹤0.01% | 1242 |
|
|
2022
Q3 | $229K | Buy |
4,274
+1,161
| +37% | +$62.2K | ﹤0.01% | 1780 |
|
|
2022
Q2 | $173K | Sell |
3,113
-17,314
| -85% | -$962K | ﹤0.01% | 1858 |
|
|
2022
Q1 | $1.43M | Sell |
20,427
-8,905
| -30% | -$625K | ﹤0.01% | 1685 |
|
|
2021
Q4 | $2.83M | Buy |
+29,332
| New | +$2.83M | ﹤0.01% | 1381 |
|